Being a Caregiver: CAR T-Cell Therapy
This is a recording of the webinar, Being a Caregiver: CAR T-Cell Therapy, that aired on February 1, 2023.

This is a recording of the webinar, Being a Caregiver: CAR T-Cell Therapy, that aired on February 1, 2023.
This is a recording of the webinar, COVID-19 and Monkeypox: What Transplant and CAR T-cell Recipients Need to Know, that aired November 16, 2022.
Acute myeloid leukemia is a diagnosis that affects mainly older adults. Treatment options depend on the type of AML a patient has, age, prior treatment and general health. Learn the details on how recommendations for treatment are determined.
Graft-versus-host disease (GVHD) is a frequent complication after a stem cell transplant using donor cells. GVHD can affect many parts of the body including the genitals.
Prevention and Treatment of Graft-versus-Host Disease (GVHD) - Video in Spanish
CAR T-cell therapy is a promising treatment for patients who have relapsed (the disease came back after treatment) or refractory (the disease did not respond to intial thereapy) non-Hodgkin lymphoma.
Learn how stem cell transplant recipients can best protect themselves against COVID-19, and newest treatment options available if you do get COVID-19.
More than 60,000 people have myelodysplastic syndrome (MDS) in the U.S. Learn about the best treatment options.
Learn about the different types of acute myeloid leukemia (AML), how it is treated, and when transplant is the best option.
CAR T-cell and other new drugs are expanding treatment options for patients with myeloma.